BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 8886149)

  • 1. Experience with carbimazole in the treatment of the hyperthyroidism of Graves' disease in Nigerian patients.
    Modebe O
    Afr J Med Med Sci; 1995 Dec; 24(4):347-51. PubMed ID: 8886149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Experience with carbimazole in the drug treatment of the hyperthyroidism of Graves' diseases in Nigerians.
    Modebe O
    East Afr Med J; 1992 Mar; 69(3):153-6. PubMed ID: 1505405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of effect of thyroxine in patients with Graves' hyperthyroidism who are treated with an antithyroid drug.
    McIver B; Rae P; Beckett G; Wilkinson E; Gold A; Toft A
    N Engl J Med; 1996 Jan; 334(4):220-4. PubMed ID: 8531998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Remission of Graves' hyperthyroidism treated with methimazole.
    Bolaños F; González-Ortiz M; Durón H; Sánchez C
    Rev Invest Clin; 2002; 54(4):307-10. PubMed ID: 12415954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Once daily, low dose, short term antithyroid drug treatment of Graves' disease is followed by an unacceptably high relapse rate.
    Ford HC; Feek CM; Delahunt JW
    N Z Med J; 1991 Mar; 104(907):97-8. PubMed ID: 2006072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcome of pediatric Graves' disease after treatment with antithyroid medication and radioiodine.
    Ward L; Huot C; Lambert R; Deal C; Collu R; Van Vliet G
    Clin Invest Med; 1999 Aug; 22(4):132-9. PubMed ID: 10497711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment outcome of Graves' disease in Thai children.
    Somnuke PH; Pusuwan P; Likitmaskul S; Santiprabhob J; Sawathiparnich P
    J Med Assoc Thai; 2007 Sep; 90(9):1815-20. PubMed ID: 17957924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Evaluation of the results of treatment of Graves' disease by synthetic antithyroid drugs].
    Fischer D; Poncin J; Dunet R; Dry J; Thomas M
    Sem Hop; 1977 Oct 9-16; 53(34-35):1843-9. PubMed ID: 73224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Propylthiouracil and carbimazole associated-antineutrophil cytoplasmic antibodies (ANCA) in patients with Graves' disease.
    Harper L; Chin L; Daykin J; Allahabadia A; Heward J; Gough SC; Savage CO; Franklyn JA
    Clin Endocrinol (Oxf); 2004 Jun; 60(6):671-5. PubMed ID: 15163328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Juvenile thyrotoxicosis--a South Island, New Zealand experience with long-term outcome.
    Brownlie BE; Hunt PJ; Turner JG
    N Z Med J; 2010 Apr; 123(1313):23-31. PubMed ID: 20581892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hyperthyroidism in Graves' disease--antithyroid drug treatment].
    Schumm-Draeger PM
    Z Arztl Fortbild Qualitatssich; 1999 Apr; 93 Suppl 1():41-5. PubMed ID: 10355049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of Graves' disease with the block-replace regimen of antithyroid drugs: the effect of treatment duration and immunogenetic susceptibility on relapse.
    Weetman AP; Pickerill AP; Watson P; Chatterjee VK; Edwards OM
    Q J Med; 1994 Jun; 87(6):337-41. PubMed ID: 7913766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Levels of autoantibodies against human TSH receptor predict relapse of hyperthyroidism in Graves' disease.
    Schott M; Morgenthaler NG; Fritzen R; Feldkamp J; Willenberg HS; Scherbaum WA; Seissler J
    Horm Metab Res; 2004 Feb; 36(2):92-6. PubMed ID: 15002058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The surgical treatment of Graves' disease].
    de Ruijter SH; van Dalen T; Muller AF
    Ned Tijdschr Geneeskd; 2006 Jun; 150(24):1321-5. PubMed ID: 16808361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early treatment with low fixed dose (5 mCi) radioiodine therapy is effective in Indian subjects with Graves' disease.
    Sanyal D; Mukhhopadhyay P; Pandit K; Chatterjee J; Raychaudhuri M; Mukherjee S; Chowdhury S
    J Indian Med Assoc; 2008 Jun; 106(6):360-1, 372. PubMed ID: 18839646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Juvenile hyperthyroidism: an experience.
    Bhadada S; Bhansali A; Velayutham P; Masoodi SR
    Indian Pediatr; 2006 Apr; 43(4):301-7. PubMed ID: 16651668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term carbimazole intake does not affect success rate of radioactive 131Iodine in treatment of Graves' hyperthyroidism.
    El Refaei SM; Shawkat W
    Nucl Med Commun; 2008 Jul; 29(7):642-8. PubMed ID: 18528187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term follow-up study of radioiodine treatment of hyperthyroidism.
    Metso S; Jaatinen P; Huhtala H; Luukkaala T; Oksala H; Salmi J
    Clin Endocrinol (Oxf); 2004 Nov; 61(5):641-8. PubMed ID: 15521969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of prior carbimazole on the outcome of radioiodine therapy in pediatric and adolescent Graves' disease.
    Ballal S; Soundararajan R; Singh H; Garg A; Chopra S; Bal C
    Nucl Med Commun; 2015 Jun; 36(6):566-72. PubMed ID: 25757198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Remission of Grave's disease after oral anti-thyroid drug treatment.
    Ishtiaq O; Waseem S; Haque MN; Islam N; Jabbar A
    J Coll Physicians Surg Pak; 2009 Nov; 19(11):690-3. PubMed ID: 19889263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.